COMPUTER-IMPLEMENTED METHOD, APPARATUS, SYSTEM AND COMPUTER PROGRAM FOR PROVIDING A REPRESENTATION OF THE EFFECT OF A VISUAL IMPROVEMENT CONTROL SOLUTION TO A USER - Patent application
A computer-implemented method and apparatus predict future visual impairment outcomes with and without control solutions, providing visual representations to enhance informed decision-making by users and caregivers.
Patent Information
- Application Number
- JP2024529643
- Authority / Receiving Office
- JP · JP
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2021-11-26
- Filing Date
- 2022-11-17
- Publication Date
- 2024-11-21
- Estimated Expiration
- Not applicable · inactive patent
AI Technical Summary
Children and their caregivers often lack awareness of visual impairment progression and the effectiveness of control solutions due to biased information from eye care professionals, hindering informed decision-making.
A computer-implemented method and apparatus that provides a user with a representation of the effects of visual impairment control solutions by analyzing user characteristics and behavior, predicting future outcomes with and without the solutions, and generating images for easy understanding.
Enables users and their families to make informed choices about visual impairment control solutions by visually illustrating the impact on progression, leveraging data analysis and predictive models.
Smart Images

Figure 2024543530000001_ABST
Abstract
Description
[Technical field]
[0001] Various aspects of the present disclosure relate generally to visual impairment control solutions, such as myopia control solutions, and more specifically to methods and apparatus for providing a user with a representation of the effectiveness of the visual impairment control solution. [Background technology]
[0002] Visual impairment, such as myopia, is a condition that often develops in a progressive manner and is more and more prevalent among children. Progression of myopia and high myopia can lead to consequences that affect the child's future quality of life (visual function, visual quality, appearance, visual health, etc.).
[0003] Many kinds of products can be used to slow the progression of myopia, such as ophthalmic lenses, contact lenses, or drugs. For example, it is known to use myopia correcting lenses of the progressive multifocal ophthalmic lens type to avoid the progression of myopia caused by such poor imaging. Bifocal lenses can also be an example of ophthalmic lenses that can be used to slow the progression of myopia.
[0004] An eye care professional (ECP) needs to educate the user or a stakeholder of the user about the importance of a vision impairment control solution before the patient can benefit from such a solution. A stakeholder is anyone who influences or determines the choice of a vision impairment control solution, such as the user's parent, the user's family, or the user's legal guardian. However, the user or the user's parent may have less knowledge about vision impairment, the dynamics of vision impairment progression, and vision impairment control solutions. The user or the user's parent can only rely on the explanations of the ECP, which may be perceived as having a commercial interest in distributing such solutions and may lack objective information to make a decision. [Prior art documents] [Patent documents]
[0005] [Patent Document 1] European Patent No. 2629140 [Non-patent literature]
[0006] [Non-Patent Document 1] "IMI Impact of Myopia," more specifically described in Table 3 of this paper. This paper was published in Investigative Ophthalmology & Visual Science April 2021, Vol. 62, 2 Summary of the Invention [Problem to be solved by the invention]
[0007] Therefore, a solution is needed to allow users to experience the future benefits of visual impairment control solutions while they currently cannot. [Means for solving the problem]
[0008] The following presents a simplified summary to provide a basic understanding of various aspects of the disclosure. This summary is not an extensive overview of all contemplated aspects, and is not intended to identify key or essential elements of all aspects or to delineate the scope of any or all aspects. Its sole purpose is to present some concepts of one or more aspects in a simplified form as a prelude to the more detailed description that is presented later.
[0009] One aspect of the present disclosure is a computer-implemented method for providing a user with a representation of an effect of a visual obstacle control solution on the user, the computer-implemented method including steps of obtaining data representing at least one characteristic of the visual obstacle control solution, at least one current characteristic of the user, and user behavior, determining at least one first future characteristic of the user if the user uses the visual obstacle control solution and determining at least one second future characteristic of the user if the user does not use the visual obstacle control solution based on the model and the data, and generating a first image based on the at least one first future characteristic and a second image based on the at least one second future characteristic.
[0010] Another aspect of the disclosure is an apparatus for providing a user with a representation of an effect of a visual hindrance control solution on the user, the apparatus including a memory and at least one processor coupled to the memory, the processor configured to obtain data representative of at least one characteristic of the visual hindrance control solution, at least one current characteristic of the user, and a behavior of the user, determine at least one first future characteristic of the user if the user uses the visual hindrance control solution and at least one second future characteristic of the user if the user does not use the visual hindrance control solution based on the model and the data, and generate a first image based on the at least one first future characteristic and a second image based on the at least one second future characteristic.
[0011] In one embodiment, the device also includes a display configured to display the first image and / or the second image and / or a camera configured to capture an image of the user's face.
[0012] Another aspect of the present disclosure is a system including the device and the visual impairment control solution.
[0013] In one embodiment of the system, the visual impairment control solution includes at least one ophthalmic lens.
[0014] In one embodiment of the system, the at least one ophthalmic lens is characterized by refractive power at at least one location, for example, near or distance viewing.
[0015] In one embodiment of the system, the visual impairment control solution is a myopia control solution, and the myopia control solution includes at least a device for performing one of the following actions or performing several of the actions simultaneously: - correcting or reducing accommodative lag during near vision activities; - correcting peripheral hyperopic defocus or providing myopic defocus, - providing retinal stimulation; - Providing different contrasts in the user's peripheral vision; - Limiting the amount of red light entering the user's eye, reducing ocular chromatic aberration; - providing light having a particular wavelength to the eye to inhibit axial elongation; - Providing dynamically changing light stimuli such as blinking, - providing a drug for modulating retinal and scleral muscarinic receptors; - Reshaping the cornea of the eye to reduce refractive defects; - Providing myopic defocus and / or optical aberrations in the retinal periphery by flattening the shape of the cornea.
[0016] Another aspect of the present disclosure is a computer program for providing a user with a representation of an effect of a visual obstacle control solution on the user, the computer program including instructions that, when executed by a computer, cause the computer to perform the steps of acquiring data representing at least one characteristic of the visual obstacle control solution, at least one current characteristic of the user, and the user's behavior, determining at least one first future characteristic of the user if the user uses the visual obstacle control solution and determining at least one second future characteristic of the user if the user does not use the visual obstacle control solution based on the model and the data, and generating a first image based on the at least one first future characteristic and a second image based on the at least one second future characteristic.
[0017] For a more detailed understanding of the description provided herein and the advantages thereof, reference is now made to the following simplified description in connection with the accompanying drawings and detailed description, in which like reference numerals represent like parts. [Brief description of the drawings]
[0018] [Figure 1] 1 is a schematic diagram of a system for providing a user with a representation of the effectiveness of a visual impairment control solution. [Diagram 2] 1 is a schematic diagram of an apparatus for providing a user with a representation of the effectiveness of a visual impairment control solution; [Diagram 3] 1 is a schematic diagram of a method for providing a user with a representation of the effectiveness of a visual impairment control solution. [Figure 4] 1 is an example of data contained in a data bank of patients using and not using a visual impairment control solution. [Diagram 5] FIG. 13 is another schematic diagram of a method for providing a user with a representation of the effectiveness of a visual impairment control solution. [Figure 6] This is an image showing the effectiveness of the visual impairment control solution. [Figure 7]1 is an image of a side view of a lens. [Figure 8] 1 is an image of a side view of a user's eye. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
[0019] The detailed description set forth below in conjunction with the accompanying drawings is intended to describe various possible embodiments and is not intended to represent the only embodiment for implementing the concepts described herein. The detailed description includes specific details to provide a thorough understanding of various concepts. However, it will be apparent to those skilled in the art that these concepts may be practiced without these specific details. In some instances, well-known structures and elements are shown in block diagram form to avoid obscuring such concepts.
[0020] One embodiment depicted in Figure 1 relates to a system 101 for providing a user with a representation of the effect of a visual impairment control solution 103. The system includes an apparatus 102 and a visual impairment control solution 103. The apparatus is configured to provide a user with a representation of the effect of the visual impairment control solution.
[0021] 2 illustrates a device 102. The device 102 includes a memory 102-a and a processor 102-b coupled to the memory 102-a. The device may also include a display 102-c and a camera 102-d. The camera 102-d may be configured to capture an image of a user's face, for example.
[0022] Examples of processors include microprocessors, microcontrollers, graphics processing units (GPUs), central processing units (CPUs), application processors, digital signal processors (DSPs), reduced instruction set computing (RISC) processors, systems on chips (SoCs), baseband processors, field programmable gate arrays (FPGAs), programmable logic devices (PLDs), state machines, gate logic, discrete hardware circuits, and other suitable hardware configured to perform various functions described throughout this disclosure.
[0023] The memory 102-a is a computer-readable medium. By way of example, and without limitation, such computer-readable medium may include random access memory (RAM), read-only memory (ROM), electrically erasable programmable ROM (EEPROM), optical disk storage, magnetic disk storage, other magnetic storage, combinations of the above types of computer-readable media, or any other medium usable to store computer-executable code in the form of instructions or data structures accessible by a computer.
[0024] The memory 102-a is configured to store a computer program including instructions which, when executed by the processor 102-b, cause the device 102 to perform steps of a method for providing a user with a representation of the effect of a visual impairment control solution.
[0025] FIG. 3 illustrates a method for providing a user with a representation of the effectiveness of a visual impairment control solution.
[0026] The method of FIG. - obtaining 301 data representative of the characteristics of the visual impairment control solution 103, the current characteristics of the user and the user's behavior; - determining 302 a first future characteristic of the user if the user uses the visual impairment control solution 103 and a second future characteristic of the user if the user does not use the visual impairment control solution 103 based on the model and the data; - generating 304 a first image based on the first future characteristic and a second image based on the second future characteristic; Includes.
[0027] The user not using a visual impairment control solution 103 means that the user does not use any visual impairment control solution 103 or the user uses a different type of visual impairment control solution 103 .
[0028] The system 101 allows a given user to provide an estimate of the progression of their vision impairment (with standard correction, not with vision impairment control) based on their data. The system 101 also allows for an estimate of the progression of the user's vision impairment using a vision impairment control solution and for this estimate to be displayed in an easy to understand manner.
[0029] The system 101 allows the user or the user's relatives to easily understand the impact of the choice of the solution on the progression of the visual impairment, and allows the user or the user's relatives to make an informed choice.
[0030] A model may, for example, include a number of cases, each case associated with a patient, an indication of the patient's use of a visual impairment control solution, at least one characteristic of the patient, the patient's behavior, and the progression of the patient's visual impairment.
[0031] The first future characteristic of the user and the second future characteristic of the user may relate to the myopia of the user. More precisely, they may represent a level of myopia.
[0032] The level of myopia can be expressed in different ways: - Spherical error: monocular and / or binocular spherical equivalent, refractive index or prescription, - axial length: left eye, right eye, average of both eyes, supplemented or not by corneal parameters (K1, K2), - Presence or absence of myopia (at a given age).
[0033] The step 302 of determining the first future characteristic of the user and the second future characteristic of the user is realized based on the following. - Any optometric parameters (visual acuity, binocular measurements, etc.) - Arbitrary behavioral parameters (time spent outdoors, time spent using near vision) - any genetic parameters (number of parents with myopia, number of siblings with myopia, etc.)
[0034] In summary, the current characteristics of the user and / or patient include some or all of the following characteristics: - spherical equivalent for eyes and age, - the spherical error of the user's right and / or left eye, and / or - monocular and / or binocular spherical equivalent for the right and / or left eye, and / or - the refractive index or prescription for the right and / or left eye, and / or - the axial length of the left eye and / or the right eye or the average of the axial length of the left eye and the axial length of the right eye, and / or - at least one corneal parameter of the left and / or right eye, and / or - signs of the presence of myopia in the left and / or right eye, and / or - The variation of any of the above mentioned characteristics over a given period of time.
[0035] User behavior includes the proportion of time spent in near and far vision.
[0036] In one embodiment, determining 302 the first future characteristic and the second future characteristic includes: - selecting from among the cases a first case associated with a patient not using the visual impairment control solution 103 and with characteristics and / or behavior of the patient that are closest to the characteristics and / or behavior of the user, - selecting from the cases a second case associated with a patient using the visual impairment control solution 103 and with characteristics and / or behaviors of the patient that are closest to the characteristics and / or behaviors of the user; - determining a first future characteristic based on the user's current visual impairment and the progression of the visual impairment of the first case patient; - determining a second future characteristic based on the user's current visual impairment and the progression of the visual impairment of the second case patient; Includes.
[0037] In other words, in this embodiment, the model is a general databank of existing cases, from which the closest cases to be compared with the current user are extracted and serve as estimates (cases available in internal databases, scientific publications, etc.) The bank can also be formed by family members (which may have similar genetic and behavioral factors), in which case patients are compared with siblings.
[0038] Advantageously, the bank can be constantly updated with a data set of new cases, so that the larger the sampling set, the easier it is to identify one or more myopic "doppelgangers" with the most similar profile to the user (age, ethnicity, geographical zone of residence, similar myopic family history, etc.) for carrying out the prediction. Once one or more myopic "doppelgangers" have been identified, a prediction of the effectiveness of the myopia control solution will be based on the user's doppelgangers. Optionally, based on the data of one's myopic "doppelgangers", specific recommendations can be made to improve lifestyle habits, for example to increase the wearing time of the solution and adopt a longer reading distance when performing close-up tasks.
[0039] Figure 4 is an example of this data contained in the databank.
[0040] Typically, this databank is filled during clinical trials involving a control group of patients and a test group of patients.
[0041] Patients in the control group are not using myopia correction solutions, whereas patients in the test group are using myopia control solutions.
[0042] For example, patients in the control group used classic ophthalmic monofocal lenses, while patients in the test group used a myopia control solution.
[0043] For each control and test patient, the progression of myopia was tracked by determining the value of a magnitude representative of the degree of myopia for each control and test patient at different times during the clinical trial. The axial length or axial elongation of the eye (the difference between the current value of the axial length and the reference value) is an example of such a magnitude representative of the degree of myopia of the eye. The spherical equivalent of the eye or the absolute value of the spherical equivalent is another example. The aforementioned magnitude representative of the degree of myopia of the eye can be determined, for example, based on the power of the ideal refractive correction required for the eye, measured in diopters.
[0044] This embodiment may be implemented as follows: For a given user (user A) with a particular age (age_A) at the time of the visit and particular spherical equivalent (SE) correction values (seR_A, seL_A) for each eye of the user. The selection criteria may be as follows: within the database of existing cases, the algorithm will return all cases (cases include all data points: spherical equivalent + age at each visit). Depending on whether case x contains at least one point, - seR_x is in the range [seR_A-0.25;seR_A+0.25] (in diopters), - age_x is in the range [age_A-0.5;age_A+0.5] (in years). The search for similar cases can be based on either eye or both eyes (seR_A and seL_A).
[0045] The points considered for case x may be the coordinates (age, spherical equivalent) for each visit of a given patient. To increase the number of cases found, an interpolation method may be used. In this case, the spherical equivalent of user x may be provided as the result of the following function: seR_x=f(age_x). The comparison of the individual points is therefore performed on the curve of the aforementioned function.
[0046] Alternatively, the comparison can be performed at several points. For user A, if we have two consecutive points: (age_1A,seR_1A) and (age_2A,seR_2A). Using the formula speed_A=(seR_2A-seR_1A) / (age_2A-age_1A) [units: diopters per year], the myopia progression speed can be calculated. In this case, the selection step therefore amounts to identifying patients with similar ages (age_2A±0.5 years) and similar progression speeds (speed_A±0.125 diopters per year). This comparison can be performed for one or the other eye or both. This comparison can also be performed on an interpolation (function), in which case the comparison is made with the slope of the curve.
[0047] In one embodiment, to preserve single-case confidentiality, the algorithm may return the average value of the selected cases.
[0048] In one embodiment, the step 302 of determining the first future characteristic of the user and the second future characteristic of the user is realized based on reference to a percentile model: a description of the level of myopia of a representative population is assumed for various time periods and the user is placed in that population. Using the closest percentile makes it possible to predict the progression of myopia. Such models can be derived from epidemiological studies (based on data collection, published or unpublished in the scientific literature). Such percentile models are currently commonly used in various areas of health care (height / weight / etc. with child growth).
[0049] In one embodiment, the step 302 of determining the first future characteristic of the user and the second future characteristic of the user is realized using a personalized myopia prediction model. The personalized myopia prediction model can be obtained using the method described in WO2011000777. The computer-based model derives a prediction of the future myopia level from input parameters. The model can be empirical, based on machine learning trained by theoretical or actual population data.
[0050] In one embodiment, step 302 of determining the first future characteristic of the user and the second future characteristic of the user is performed by the ECP himself based on his experience, i.e., the ECP inputs the levels of myopia that he has observed in similar patients.
[0051] In one embodiment, step 302 of determining the first future characteristic of the user and the second future characteristic of the user is achieved by training a neural network using a plurality of cases, at least one case being associated with the patient, an indication of the patient's use of the visual impairment control solution 103, at least one characteristic of the patient, the patient's behavior and the progression of the patient's visual impairment.
[0052] In other words, in this embodiment, the model is based on machine learning and the training data set may include patients who use the visual impairment control solution 103. Thus, step 302 may predict the level of visual impairment with the visual impairment control solution 103 and without the visual impairment control solution 103.
[0053] In one embodiment, the visual impairment control solution 103 includes an ophthalmic lens and at least one property of the visual impairment control solution 103 is an optical property. The visual impairment control solution 103 may be a myopia control solution.
[0054] In one embodiment, the optical characteristics of the vision impairment control solution 103 include the refractive power at a location of the ophthalmic lens.
[0055] In some embodiments, the one location may include at least one of a near or far viewpoint of an Ophthalmic Lens.
[0056] In one embodiment, the visual impairment control solution 103 is a myopia control solution, and the myopia control solution comprises at least - correcting or reducing accommodative lag during near vision activities; - correcting peripheral hyperopic defocus or providing myopic defocus, - providing retinal stimulation; - Providing different contrasts in the user's peripheral vision; - Limiting the amount of red light entering the user's eye, reducing ocular chromatic aberration; - providing light having a particular wavelength to the eye to inhibit axial elongation; - Providing dynamically changing light stimuli such as blinking, - providing a drug for modulating retinal and scleral muscarinic receptors; - Reshaping the cornea of the eye to reduce refractive defects; - Providing myopic defocus and / or optical aberrations in the retinal periphery by flattening the shape of the cornea The term "device" includes a device for performing one of the above or for performing several of the above operations simultaneously.
[0057] Other types of myopia control solutions may be used that have been described, tested, and are currently in use to limit the progression of myopia in subjects.
[0058] The ocular accommodative lag is defined as the difference between accommodative demand and accommodative response, resulting in residual refractive error.
[0059] Each myopia control solution may include one or more of the basic myopia control solutions as described above. In practice, these operations are performed in five types of devices for controlling myopia: - ophthalmic lenses integrated into spectacles; - contact lenses worn directly on the subject's eye; a light source, for example to reproduce daylight indoors or to avoid emitting wavelengths that cause eye elongation; - filters such as blue-cut filters that remove wavelengths that cause eye elongation, for example filters integrated into the lens or including digital screen filters; - Pharmaceutical products.
[0060] Each myopia control solution may perform one or more of the actions listed above. Each myopia control solution may use one or more devices to control myopia.
[0061] For example, correcting or reducing the accommodative lag during near vision activities is performed using a lens with positive spherical refractive power in the lens area used for near vision work.This can be a bifocal lens with a zone in which the positive sphere is located in the near vision area of the lens, or a progressive lens with an additional power in the near vision area.An example of a bifocal lens used to control myopia can be a prism bifocal lens with two optical zones, the zone located in the far vision area (top of the lens) compensates for the myopic refractive defect of the eye, while the zone located in the near vision area (bottom of the lens) reduces the accommodative demand for viewing at the near end, and therefore the accommodative lag.
[0062] Correcting peripheral hyperopic defocus or providing myopic defocus can be achieved by using a lens with positive spherical power at the periphery of the lens.
[0063] A customized lens can be used that provides retinal stimulation using multiple light stimuli positioned in front of the retina of the subject's eye, including: - a refractive zone having a first refractive power based on a prescription for correcting anomalous refraction of the eye; and - a plurality of at least three optical elements, at least one optical element having an optical function that does not focus images on the retina of the eye so as to slow the progression of anomalous refraction of the eye.
[0064] Such lenses are described, for example, in WO2019166654.
[0065] Providing different contrast in peripheral vision can be achieved by inserting scattering elements at the periphery of the lens.
[0066] Limiting the amount of red light that enters the eye can be accomplished, for example, using a specific filter integrated into the lens.
[0067] Limiting the amount of red light that enters the eye can be accomplished, for example, using a specific filter integrated into the lens.
[0068] Providing light having specific wavelengths to the eye to inhibit axial elongation can be accomplished by phototherapy, which involves exposing the eye to wavelengths that trigger dopamine receptors that regulate axial elongation.
[0069] Providing a dynamically changing light stimulus can be achieved by exposing the eye to a sinusoidal modulation of white light (along with blue or yellow light) according to a temporal frequency.
[0070] Providing a drug to modulate retinal and scleral muscarinic receptors can be accomplished, for example, by providing topical atropine delivered directly to the subject's eye using eye drops. Other pharmacological approaches that have been attempted for myopia control include topical timolol, a non-selective beta-adrenergic blocker, and oral 7-methylxanthine (7-MX), an adenosine antagonist. The efficacy of atropine for myopia control has been shown in several studies, including the following: Wu, P.-C., Chuang, M.-N., Choi, J., Chen, H., Wu, G., Ohno-Matsui, K., Jonas, JB, Cheung, CMG, 2019, <<Update in myopia and treatment strategy of atropine use in myopia control> >in Eye 33,3-13.
[0071] The effects of drugs that may be administered to the eye typically last for at least several hours, and for this reason, the use of drugs is considered concurrent when administered together with another myopia control solution.
[0072] Corneal reshaping, also known as orthokeratology, is performed by fitting a specially designed, gas permeable contact lens onto the subject's eye, which is typically flattened and reshapes the eye's cornea to reduce the refractive defect of myopia.
[0073] Flattening the shape of the cornea to reduce myopic defocus and / or optical aberrations in the retinal periphery can be achieved, for example, with an Ortho-K solution.
[0074] Any other myopia control solution known to a person skilled in the art may be considered. All possible combinations of basic myopia control solutions may be considered and therefore may be included in the aforementioned database 101 of the aforementioned memory 100. In general, a combination of two basic myopia control solutions may be considered, for example, the use of a pharmaceutical product such as atropine in combination with any other myopia control solution. A combination lens may be considered that provides retinal stimulation with the use of a positive sphere zone in the near vision region.
[0075] The effectiveness of the aforementioned myopia control solution is defined as a measure that represents the ability of the myopia control solution to produce a desired or intended result in controlling the wearer's myopia. Effectiveness may be quantified, for example, as a percentage value, for example 100% being maximum effectiveness and 0% being minimum effectiveness.
[0076] In one embodiment presented in FIG. 5, a method for providing a user with a representation of the effectiveness of a visual obstruction control solution. In this embodiment, the method includes: - a step 501 of determining a first optical article based on at least one first future characteristic of a user; - determining 502 a second optical article based on at least one second future characteristic of the user; Includes.
[0077] In one embodiment, the first image is an image of the face of a user wearing a first optical article, and the second image is an image of the face of a user wearing a second optical article. Figure 6 is an example of these two images. Figure 6A is a representation of the user's face when the user is wearing the first optical article, and Figure 6B is a representation of the user's face when the user is wearing the second optical article. In the first case, the user is wearing a visual impairment control solution 103, in which case the first optical article has a smaller refractive power than the second optical article, since the visual impairment is smaller. Due to this reduction in refractive power, the temporary jump and shrinkage of the eye seen through the lens is smaller in Figure 6A than in Figure 6B. The temporary jump is an optical effect caused by wearing a myopic lens that creates a lateral shift to the tip of the temples of the wearer's glasses, visible to an observer in front of the wearer. The myopia ring is smaller in Figure 6A than in Figure 6B. A myopia ring is an optical effect resulting from wearing a myopic lens, visible to an observer positioned to the side of the wearer, resulting in a white circle at the edge of the lens. EP 2629140 B1 describes an embodiment of an image of a user's face wearing a first optical article and the generation of an image of a user's face wearing the first optical article.
[0078] In another embodiment, the first image is an image of a first lenticular shape and the second image is an image of a second lenticular shape. Figure 7 is an example of these two images.
[0079] In one embodiment, the first image and the second image are side view (e.g., two-dimensional or 2D side view) images of the eye. Typically, the first image is of a more myopic eye than the second image. Figure 8 is an example of these two images.
[0080] In one embodiment, the first image and the second image are tables including risk of eye disease associated with the first and second future characteristics of the user. These risks are described in the article "IMI Impact of Myopia", more specifically in Table 3 of the article. The article is published in Investigative Ophthalmology & Visual Science April 2021, Vol. 62, 2 and is accessible from the following webpage: https: / / iovs.arvojournals.org / article.aspx?articleid=2772540. [Explanation of symbols]
[0081] 100 Memory 101 System 102 Equipment 102-a Memory 102-b processor 102-c Display 102-d Camera 103 Visual Impairment Control Solutions
Claims
1. 1. A computer-implemented method for providing a user with a representation of an effect on the user of a visual impairment control solution (103), comprising: - obtaining (301) data representative of at least one characteristic of said visual impairment control solution, at least one current characteristic of said user and a behavior of said user; - determining (302) based on the model and on the data at least one first future characteristic of the user if the user uses the visual impairment control solution (103) and at least one second future characteristic of the user if the user does not use the visual impairment control solution (103); - generating (303) a first image based on said at least one first future characteristic and a second image based on said at least one second future characteristic; 23. A computer-implemented method comprising:
2. The model includes a plurality of cases, at least one case being associated with a patient, an indication of the patient's use of the visual impairment control solution (103), at least one characteristic of the patient, the patient's behavior, and a progression of the patient's visual impairment, and the step of determining the at least one first future characteristic and the at least one second future characteristic includes: selecting from said cases a first case associated with a patient not using said visual impairment control solution (103) and with said at least one characteristic and / or said behavior of said patient that is closest to said at least one characteristic and / or said behavior of said user, selecting from said cases a second case associated with a patient using said visual impairment control solution (103) and with said at least one characteristic and / or said behavior of said patient that is closest to said at least one characteristic and / or said behavior of said user, determining said at least one first future characteristic based on a current visual impairment of said user and on said progression of said visual impairment of said patient in said first case; determining said at least one second future characteristic based on said current visual impairment of said user and on said progression of said visual impairment of said patient in said second case; The computer-implemented method of claim 1 , comprising:
3. 2. The computer-implemented method of claim 1, wherein the model is a neural network, and the computer-implemented method also includes a step of training the neural network by using a plurality of cases, at least one case being associated with a patient, an indication of the patient's use of the visual impairment control solution (103), at least one characteristic of the patient, the patient's behavior, and the progression of the patient's visual impairment.
4. The computer-implemented method of any one of claims 1 to 3, wherein the at least one current characteristic of the user and / or patient comprises an ocular spherical equivalent and / or an age.
5. The at least one characteristic of the user and / or the at least one future characteristic of the user may be the spherical error of the right and / or left eye of said user, and / or the monocular and / or binocular spherical equivalent of the right eye and / or the left eye, and / or - the refractive index or prescription for said right eye and / or said left eye, and / or the axial length of the left eye and / or the right eye or the average of the axial length of the left eye and the axial length of the right eye, and / or at least one corneal parameter of the left eye and / or the right eye, and / or - indications of the presence of myopia in said left eye and / or in said right eye, and / or - variation of at least one of the spherical error, the monocular spherical equivalent, the binocular spherical equivalent, the refractive index, the prescription, the axial length, the at least one corneal parameter or the indication over a given period of time, The computer-implemented method of any one of claims 1 to 4, comprising:
6. The computer-implemented method of any one of claims 1 to 5, wherein the behavior of the user comprises a proportion of time spent in near vision and distance vision.
7. The computer-implemented method of any one of claims 1 to 6, wherein the visual impairment control solution (103) comprises at least one ophthalmic lens and the at least one property of the visual impairment control solution is an optical property.
8. The computer-implemented method of claim 7 , wherein the optical characteristics of the vision impairment control solution (103) include a refractive power at at least one location of the at least one ophthalmic lens.
9. The computer-implemented method of claim 8 , wherein the at least one location comprises at least one of a near viewpoint or a far viewpoint of the at least one ophthalmic lens.
10. The visual impairment control solution (103) is a myopia control solution, the myopia control solution having at least the following operations: - correcting or reducing accommodative lag during near vision activities, - correcting peripheral hyperopic defocus or providing myopic defocus, - providing retinal stimulation; - providing different contrast in the peripheral vision of the user; - limiting the amount of red light entering the user's eye to reduce chromatic aberration in the eye; - providing light having a particular wavelength to said eye to inhibit axial elongation; - Providing dynamically changing light stimuli such as blinking; - providing drugs for modulating retinal and scleral muscarinic receptors; - reshaping the cornea of said eye to reduce refractive defects; - providing myopic defocus and / or optical aberrations in the retinal periphery by flattening the shape of the cornea; 7. The computer-implemented method of claim 1, further comprising a device for performing one of the operations or performing several of the operations simultaneously, and wherein the at least one characteristic of the visual impairment control solution (103) represents the operation performed by the device.
11. determining (501) a first optical article based on said at least one first future characteristic of said user; and determining (502) a second optical article based on said at least one second future characteristic of said user; 11. The computer-implemented method of claim 1, further comprising: a first image being an image of the face of the user wearing the first optical article; and a second image being an image of the face of the user wearing the second optical article.
12. determining (501) a first optical article based on said at least one first future characteristic of said user; and determining (502) a second optical article based on said at least one second future characteristic of said user; 11. The computer-implemented method of claim 1, further comprising: a first optical article comprising a first lens and a second optical article comprising a second lens, the first image being an image of a shape of the first lens and the second image being an image of a shape of the second lens.
13. An apparatus (102) for providing a user with a representation of an effect on the user of a visual impairment control solution (103), comprising: a memory (102-a); and at least one processor (102-b) coupled to the memory (102-a), the at least one processor (102-b) comprising: - obtaining data representative of at least one characteristic of said visual impairment control solution, at least one current characteristic of said user and a behavior of said user; - determining, based on the model and the data, at least one first future characteristic of the user if the user uses the visual impairment control solution (103) and at least one second future characteristic of the user if the user does not use the visual impairment control solution (103); generating a first image based on said at least one first future characteristic and a second image based on said at least one second future characteristic; An apparatus (102) configured to:
14. A system (101) comprising an apparatus (102) according to claim 13 and a visual impairment control solution (103).
15. 1. A computer program for providing a user with a representation of an effect on the user of a visual impairment control solution (103), the computer program comprising instructions, when the computer program is executed by a computer, that cause the computer to: - obtaining (301) data representative of at least one characteristic of said visual impairment control solution, at least one current characteristic of said user and a behavior of said user; - determining (302) based on the model and on the data at least one first future characteristic of the user if the user uses the visual impairment control solution (103) and at least one second future characteristic of the user if the user does not use the visual impairment control solution (103); - generating (303) a first image based on said at least one first future characteristic and a second image based on said at least one second future characteristic; A computer program that causes the
Citation Information
Patent Citations
Spectacle lens image generation method and device
JP1999272728A
Accurate prediction and treatment of myopic progression by artificial intelligence
WO2020083382A1
Simulation system for wearing spectacles, simulation device for wearing spectacles and simulation program for wearing spectacles
EP2629140A1
